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Possibly still are health professionals that when
hearing about adverse drug reactions only think in
cutaneous rash, blood dyscrasias, anaphylactic shock
and congenital malformations. The mentioned adverse
effects are real, but relatively infrequent. Furthermore,
are unexpected, not related with the pharmacological
mechanism of action, unpredictable and dose independent.
These adverse drug reactions are like a therapeutic
lottery, depending on «luck».
However, when the pharmacological pathology
resulting in medical care is analyzed, the perspective is
very different. For instance, the predominant adverse
drug reactions in emergency wards are those related with
the pharmacological mechanism of action: severe
hemorrhage due to anticoagulant and antiplatelet drugs;
renal insufficiency and hyperkalemia by inhibitors of the
renin-angiotensin axis; hyponatremia, fells and fractu-
res by SSRI antidepressants, digitalis intoxication…
These are relatively common pathologies, expectable,
dose-related, and favored by patient comorbidity,
preventable in many cases if the dose would have
carefully individualized, if the patient complied better
with the instructions (in case the patient understood the
information) or if a more carefully clinical surveillance
were performed.
A review of the literature reminds us other pathologies
attended in other assistance levels, for example:
- Breast cancer attributable to the hormone replacement
therapy (HRT): three to four additional cases per
1.000 women treated during 5 years, this is translated
in thousands of additional cases of breast cancer
according to the sales data of these products between
the years 1993 to 2003. Moreover, it was irresponsibly
promoted for the prevention of cardiovascular events,
dementia, and as the source of eternal youth without
proven efficacy at that time (no evidence of efficacy
exist today).
- Non-steroidal anti-inflammatory drugs (NSAIDs) -
especially celecoxib and diclofenac -increase the risk
of acute myocardial infarct in 50-70%, because their
high consumption by elderly people, these drugs are
associated with a considerable number of deaths by
myocardial infarct.
- Proton pump inhibitors, SSRI antidepressants,
benzodiacepines, and antipsychotics are the cause
thousands of cases of femoral neck fracture in elderly
people.
- High dose of erythropoietin (to achieve a level of 12g/
dL of hemoglobin or more) increase the mortality in
25%, therefore, one additional death is induced by
the treatment of four patients.
The previous adverse reactions are only some
examples. The list is very long, covering all medical and
surgical specialties, and practically any pathology: For
instance, obesity and parkinsonism by antipsychotics
and prokinetics, increase in the risk of suicide by the use
of SSRI antidepressants in children’s and antiepileptic
agents in adults (frequently in no approved indications),
stroke and death secondary to antipsychotics, respiratory
depression by fentanyl and opiate derivatives, traffic
accidents by CNS depressants, cancer by immuno-
suppressive agents, resistant and opportunistic
nosocomial infections secondary to broad spectrum
antibiotics, fractures by thiazolidinediones, cancer by
ezetimibe… In some highly specialized areas we should
recognize that we know almost nothing; for instance
let’s reflect on the safety of the new and old antineoplastic
chemotherapeutic agents in real practice.
Studies on the usage of medicaments unequivocally
indicate that many drugs are unnecessary consumed by
people, as well as the opposite, many people needing the
medication do not consume it by lack of access or other
reasons. Both situations originate an unnecessary and
preventable pathology. An important part of the iatrogenic
pathology that affects the population might be the
consequence of the non-rational prescription of unneeded
drugs or the prescription of medicaments that are not the
first choice. A particular concern is the pressure for the
prescription of new drugs, patent protected, more
expensive, not even directly compared in Randomized
Clinical Trials with already available agents. Remember
Vioxx®: New drugs are associated with major uncertainty
regarding their safety.
The influence of commercial promotion on drug
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prescription is undeniable: It is necessary to remember
that commercial innovation is not equivalent to
therapeutic innovation, meaning that increased efficacy
equals additional safety, more comfort and improved life
quality for our patients. The only truth is that new
therapeutic agents are more expensive compared to
well-known alternatives with more experience of usage.
Rational, reflexive and prudent prescription of drugs
is not only a physician responsibility. Health care systems
and health insurers have the responsibility to provide
continuous formation to their workers with independence
from the pharmaceutical industry, along with the
facilitation of medical practice by the means of selecting
the best alternatives for each health related problem,
allowing more focus to manage the knowledge of
problems that are really essential.
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